Are patients with schizophrenia treated less with second-line glucose-lowering drugs for type 2 diabetes?

Søren L. Jacobsen; Ole Köhler-Forsberg; Christopher Rohde

doi:10.1016/j.schres.2024.06.030

Are patients with schizophrenia treated less with second-line glucose-lowering drugs for type 2 diabetes?

Søren L. Jacobsen^*, Ole Köhler-Forsberg, Christopher Rohde

^*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review

Original language	English
Journal	Schizophrenia Research
Volume	270
Pages (from-to)	231-234
Number of pages	4
ISSN	0920-9964
DOIs	https://doi.org/10.1016/j.schres.2024.06.030
Publication status	Published - Aug 2024

Keywords

Diabetes-related complications
Glucose-lowering drugs
Schizophrenia
Type 2 diabetes

Access to Document

10.1016/j.schres.2024.06.030

Cite this

@article{5baebf51caf44079bd9a83400d727d07,

title = "Are patients with schizophrenia treated less with second-line glucose-lowering drugs for type 2 diabetes?",

keywords = "Diabetes-related complications, Glucose-lowering drugs, Schizophrenia, Type 2 diabetes",

author = "Jacobsen, {S{\o}ren L.} and Ole K{\"o}hler-Forsberg and Christopher Rohde",

year = "2024",

month = aug,

doi = "10.1016/j.schres.2024.06.030",

language = "English",

volume = "270",

pages = "231--234",

journal = "Schizophrenia Research",

issn = "0920-9964",

publisher = "Elsevier B.V.",

}

Are patients with schizophrenia treated less with second-line glucose-lowering drugs for type 2 diabetes? / Jacobsen, Søren L.; Köhler-Forsberg, Ole; Rohde, Christopher.
In: Schizophrenia Research, Vol. 270, 08.2024, p. 231-234.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review